Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Straumann Holding AG
  6. News
  7. Summary
    STMN   CH1175448666

STRAUMANN HOLDING AG

(STMN)
  Report
Real-time Estimate Cboe Europe  -  07:14:04 2023-06-02 am EDT
136.98 CHF   +1.39%
05/25Global markets live: Nvidia, Snowflake, Best Buy, Verizon, Microsoft...
MS
05/25Straumann Holding AG acquired GalvoSurge Dental AG.
CI
05/09Kepler Cheuvreux Lifts Price Target on Straumann, Maintains Buy Recommendation
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Straumann invests in RODO Medical

08/13/2014 | 01:35am EDT

Straumann invests in RODO Medical

  • Straumann purchases approximately 12% of RODO Medical's shares for an undisclosed sum.
  • RODO Medical's highly innovative Smileloc™ System could have an important impact on implant prosthetic design, replacing cement and screws in implant restorations.

Basel/Sunnyvale, 13 August 2014: Straumann, a global leader in replacement, restorative and regenerative dentistry, and RODO Medical, Inc., a privately-held company developing innovative devices in dental implant restorations, have signed an agreement under which Straumann has acquired approximately 12% of RODO Medical's shares for an undisclosed sum.

The innovative Smileloc™ System

At the heart of the RODO Medical's Smileloc™ System is a retention mechanism utilizing shape memory properties of 'nitinol', a nickel-titanium alloy, which has been safely used for decades in stents and other medical devices, including orthodontic archwire and edotontic files. With Smileloc™, the crown or denture (prosthesis), can simply be fixed to the implant abutment without the need for cement or retaining screws. The Smileloc™ System eliminates disadvantages associated with cement and screws, and significantly simplifies the existing implant restoration process by allowing quick and easy removal of the prosthesis. This in turn can dramatically cut procedure time and cost without sacrificing esthetics. For more information, please visit www.rodomedical.com.

Straumann's CEO Marco Gadola commented: "Smileloc is an innovative concept designed to address a significant need. The first clinical results are promising and I agree with the developers that, when it becomes commercially available, it might substitute some of the current fixture technology. RODO Medical's entrepreneurial and scientific approach to innovation makes them an attractive partner for Straumann and we are excited about working together with them to change paradigms in dentistry".

RODO Medical's CEO Young Seo commented: "We are very excited about Straumann's investment in the company. Straumann is the global market leader in the dental implant industry and highly respected for its reliable products and responsible innovations".

About RODO Medical

RODO Medical is an innovative medical device company dedicated to improving the quality of life of patients and dentists. The company was founded in 2009 and is located in Sunnyvale, California. RODO Medical has developed novel retention devices in implant dentistry. The Smileloc™ System is used in permanent fixed restorations with dental implants and the Smileclip™ System is used in removable dentures with dental implants. The Smileloc™ System is not yet cleared by the FDA for marketing in the US, but has marketing clearance in Europe (CE Mark).

About Straumann

Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately 2200 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.




Provider
Channel
Contact
Tensid Ltd., Switzerland
www.tensid.ch


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
marco@tensid.ch
+41 41 763 00 50
All news about STRAUMANN HOLDING AG
05/25Global markets live: Nvidia, Snowflake, Best Buy, Verizon, Microsoft..
MS
05/25Straumann Holding AG acquired GalvoSurge Dental AG.
CI
05/09Kepler Cheuvreux Lifts Price Target on Straumann, Maintains Buy Recommendation
MT
05/03Transcript : Straumann Holding AG, Q1 2023 Sales/ Trading Statement Call, May..
CI
05/03Straumann Logs Higher Q1 Revenue
MT
05/03Straumann : First-quarter 2023 report
PU
05/03Straumann Group achieved CHF 596 million revenue in the first quarter and launched adva..
EQ
04/19Invitation : Straumann Group 2023 first-quarter sales report webcast
EQ
04/11STRAUMANN HOLDING AG : Ex-dividend day for final dividend
FA
04/05Straumann Group shareholders approve all proposals and elect Dr. Olivier Filliol as a n..
EQ
More news
Analyst Recommendations on STRAUMANN HOLDING AG
More recommendations
Financials
Sales 2023 2 464 M 2 711 M 2 711 M
Net income 2023 491 M 540 M 540 M
Net cash 2023 409 M 450 M 450 M
P/E ratio 2023 43,7x
Yield 2023 0,64%
Capitalization 21 529 M 23 691 M 23 691 M
EV / Sales 2023 8,57x
EV / Sales 2024 7,56x
Nbr of Employees 10 269
Free-Float 66,6%
Chart STRAUMANN HOLDING AG
Duration : Period :
Straumann Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRAUMANN HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 135,10 CHF
Average target price 131,88 CHF
Spread / Average Target -2,39%
EPS Revisions
Managers and Directors
Guillaume Daniellot Chief Executive Officer
Weder Marc-Alain Chief Financial Officer
Gilbert Achermann Chief Executive Officer & Director
Christian Ullrich Group Chief Information Officer
SÚbastien Roche Chief Operations & Supply Chain Officer
Sector and Competitors
1st jan.Capi. (M$)
STRAUMANN HOLDING AG27.94%23 691
SONOVA HOLDING AG7.48%15 457
COCHLEAR LIMITED21.62%10 714
DEMANT A/S39.96%8 421
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.-10.94%3 045
ÖSSUR HF.-7.60%1 879
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer